FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

C Brignola

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Co-author Network

Publications

TOP 3
C Brignola; C Belloli; Sandro Ardizzone; Marco Astegiano; Mario Cottone; Giacomo Trallori
The relationship between heritability and smoking habits in Crohn's disease. Italian Cooperative Study Group.
Paolo Gionchetti; Fernando Rizzello; A Ferrieri; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Mario Miglioli; Massimo Campieri
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; Mario Miglioli; Massimo Campieri
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of C Brignola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: C Brignola; C Belloli; Sandro Ardizzone; Marco Astegiano; Mario Cottone; Giacomo Trallori
The relationship between heritability and smoking habits in Crohn's disease. Italian Cooperative Study Group.
The American journal of gastroenterology 2000;95(11):3171-5.
1999: Paolo Gionchetti; Fernando Rizzello; A Ferrieri; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Mario Miglioli; Massimo Campieri
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
Digestive diseases and sciences 1999;44(6):1220-1.
1998: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; Mario Miglioli; Massimo Campieri
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
Diseases of the colon and rectum 1998;41(1):93-7.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; C Brignola; M Ferretti; S Peruzzo; Massimo Campieri
Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
Alimentary pharmacology & therapeutics 1997;11(6):1053-7.
1997: Roberto de Franchis; Paolo Omodei; T Ranzi; C Brignola; Rodolfo Rocca; Alberto Prada; Angelo Pera; Maurizio Vecchi; M Del Piano; A Ferrara; C Belloli; Luca P Piodi; L Framarin; Marco Astegiano; F A Riccioli; Gianmichele Meucci
Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.
Alimentary pharmacology & therapeutics 1997;11(5):845-52.
1997: Paolo Gionchetti; Fernando Rizzello; Annamaria Venturi; M Ferretti; C Brignola; S Peruzzo; C Belloli; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis.
Alimentary pharmacology & therapeutics 1997;11(4):673-8.
1997: Paolo Gionchetti; Maurizio Vecchi; Fernando Rizzello; M Ferretti; Carmen Calabresi; Annamaria Venturi; MB Bianchi; C Brignola; renato alberto sinico; Roberto de Franchis; Mario Miglioli; Massimo Campieri
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.
Gut 1997;40(1):102-4.
1997: Mario Cottone; C Brignola; M Rosselli; Lorenzo Oliva; C Belloli; C Cipolla; Ambrogio Orlando; G De Simone; M R Aiala; R Di Mitri; G Gatto; Antonio Buccellato
Relationship between site of disease and familial occurrence in Crohn's disease.
Digestive diseases and sciences 1997;42(1):129-32.
1996: Paolo Gionchetti; Massimo Campieri; Annamaria Venturi; Fernando Rizzello; M Ferretti; C Brignola; Mario Miglioli
Systemic availability of 5-aminosalicylic acid: comparison of delayed release and an azo-bond preparation.
Alimentary pharmacology & therapeutics 1996;10(4):601-5.
1996: A Belluzzi; C Brignola; Massimo Campieri; A Pera; S Boschi; Mario Miglioli
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.
The New England journal of medicine 1996;334(24):1557-60.
1996: C Brignola; C Belloli; G De Simone; Massimo Campieri; Paolo Gionchetti; A Belluzzi
Analysis of biological variables in Crohn's disease.
Gut 1996;38(6):938-9.
1996: Gilberto Poggioli; Silvio Laureti; S Selleri; C Brignola; Gian Luca Grazi; L Stocchi; C Marra; C Magalotti; W F Grigioni; Antonino Cavallari
Factors affecting recurrence in Crohn's disease. Results of a prospective audit.
International journal of colorectal disease 1996;11(6):294-8.
1996: Massimo Campieri; A Belluzzi; Paolo Gionchetti; C Brignola; M Ferretti; F Rizello; E Bertinelli; Mario Miglioli; L Barbara
[Treatment of active ulcerative colitis].
Gastroenterología y hepatología 1996;19(1):24-6.
1995: C Brignola; C Belloli; G De Simone; L Varesco; P Walger; Alessandra Areni; Carlo Calabrese; Giulio Di Febo; L Barbara
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds.
Digestive diseases and sciences 1995;40(2):402-5.
1995: C Brignola; Mario Cottone; Angelo Pera; S Ardizzone; M L Scribano; Roberto de Franchis; Agesilao D'Arienzo; Giuseppe d'Albasio; D Pennestri
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
Gastroenterology 1995;108(2):345-9.
1995: Mario Cottone; A Magliocco; Giacomo Trallori; C Brignola; C Vandelli; S Ardizzone; G Meucci; F Zannoni; G Di Maio; Marco Astegiano
Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis.
The Italian journal of gastroenterology 1995;27(1):3-4.
1994: A Belluzzi; C Brignola; Massimo Campieri; E P Camporesi; Paolo Gionchetti; Fernando Rizzello; C Belloli; G De Simone; S Boschi; Mario Miglioli
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients.
Digestive diseases and sciences 1994;39(12):2589-94.
1994: Paolo Gionchetti; Massimo Campieri; A Belluzzi; S Boschi; C Brignola; Mario Miglioli; L Barbara
Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers.
Alimentary pharmacology & therapeutics 1994;8(5):535-40.
1994: C Brignola; G De Simone; C Belloli; P Iannone; A Belluzzi; Paolo Gionchetti; Massimo Campieri; L Barbara
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration.
Alimentary pharmacology & therapeutics 1994;8(4):465-8.
1994: Paolo Gionchetti; Massimo Campieri; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; Gilberto Poggioli; Mario Miglioli; L Barbara
Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches.
Digestive diseases and sciences 1994;39(7):1525-31.
1994: Paolo Gionchetti; Dino Vaira; Massimo Campieri; john holton; Marcello Menegatti; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; Mario Miglioli
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients.
The American journal of gastroenterology 1994;89(6):883-7.
1994: Andrea Messori; C Brignola; Giacomo Trallori; R Rampazzo; G Bardazzi; C Belloli; Giuseppe d'Albasio; G De Simone; N Martini
Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.
The American journal of gastroenterology 1994;89(5):692-8.
1994: Paolo Gionchetti; Massimo Campieri; Carlo Guarnieri; A Belluzzi; C Brignola; E Bertinelli; M Ferretti; Mario Miglioli; L Barbara
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission.
Digestive diseases and sciences 1994;39(3):550-4.
1994: A Belluzzi; C Brignola; Massimo Campieri; Paolo Gionchetti; Fernando Rizzello; S Boschi; S Cunanne; Mario Miglioli; L Barbara
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 1994;8(1):127-30.
1993: A Belluzzi; M Campieri; C Brignola; Paolo Gionchetti; M Miglioli; L Barbara
Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease.
Gut 1993;34(9):1289-90.
1993: C Brignola; C Belloli; G De Simone; A Evangelisti; R Parente; R Mancini; P Iannone; E Mocheggiani; N Fabris; M C Morini
Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 1993;7(3):275-80.
1993: C Brignola; C Belloli; P Iannone; G De Simone; C Corbelli; M Levorato; V Arienti; L Boriani; Paolo Gionchetti; A Belluzzi
Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of X-ray-demonstrated lesions of Crohn's disease.
Digestive diseases and sciences 1993;38(3):433-7.
1992: Massimo Campieri; C Corbelli; Paolo Gionchetti; C Brignola; A Belluzzi; Giulio Di Febo; P Zagni; Gabriele Brunetti; Mario Miglioli; L Barbara
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.
Digestive diseases and sciences 1992;37(12):1890-7.
1992: Massimo Campieri; E Bertinelli; Paolo Gionchetti; A Belluzzi; Maria Paola Tampieri; C Brignola; Mario Miglioli; L Barbara
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis.
The Italian journal of gastroenterology 1992;24(9 Suppl 2):2-3.
1992: Paolo Gionchetti; Massimo Campieri; A Belluzzi; G M Paganelli; Maria Paola Tampieri; E Bertinelli; C Brignola; Gilberto Poggioli; Mario Miglioli; G Gozzetti
Macrophage subpopulations in pouchitis.
Gut 1992;33(7):1008.
1992: Luigi Bolondi; Stefano Gaiani; C Brignola; Massimo Campieri; A Rigamonti; Gianni Zironi; Paolo Gionchetti; C Belloli; Mario Miglioli; L Barbara
Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry.
Scandinavian journal of gastroenterology 1992;27(6):501-7.
1992: C Brignola; P Iannone; S Pasquali; Massimo Campieri; Paolo Gionchetti; A Belluzzi; O Basso; Mario Miglioli; L Barbara
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.
Digestive diseases and sciences 1992;37(1):29-32.
1992: C Brignola; G De Simone; P Iannone; C Belloli; A Evangelisti; Massimo Campieri; A Belluzzi; Paolo Gionchetti; Maria Paola Tampieri; E Bertinelli
Influence of steroid treatment's duration in patients with active Crohn's disease.
Agents and actions 1992;Spec No():C90-2.
1992: Paolo Gionchetti; Massimo Campieri; A Belluzzi; Maria Paola Tampieri; E Bertinelli; C Brignola; M Ferretti; P Boni; P Iannone; Mario Miglioli
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Agents and actions 1992;Spec No():C50-2.
1991: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
Gut 1991;32(8):929-31.
1991: Paolo Gionchetti; Massimo Campieri; A Belluzzi; P Boni; C Brignola; H Ferretti; P Iannone; Mario Miglioli; L Barbara
Interleukin 1 in ulcerative colitis.
Gut 1991;32(3):338.
1991: Paolo Gionchetti; Carlo Guarnieri; Massimo Campieri; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
Digestive diseases and sciences 1991;36(2):174-8.
1990: Paolo Gionchetti; M Schiavina; Massimo Campieri; A Fabiani; B M Cornia; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Bronchopulmonary involvement in ulcerative colitis.
Journal of clinical gastroenterology 1990;12(6):647-50.
1990: Paolo Gionchetti; Carlo Guarnieri; Massimo Campieri; A Belluzzi; C Brignola; P Iannone; Mario Miglioli; L Barbara
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ)
Gut 1990;31(6):730-1.
1990: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Gabriele Brunetti; Mario Miglioli; L Barbara
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.
International journal of colorectal disease 1990;5(2):79-81.
1990: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; A Petronelli; Mario Miglioli; L Barbara
Role of rectal formulations: enemas.
Scandinavian journal of gastroenterology. Supplement 1990;172():63-5.
1990: Paolo Gionchetti; Massimo Campieri; A Belluzzi; C Brignola; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
Pentasa in maintenance treatment of ulcerative colitis.
Gastroenterology 1990;98(1):251.
1989: C Brignola; P Iannone; S Pasquali; M Campieri; Paolo Gionchetti; A Belluzzi; C Corbelli; P Zagni; M Levorato; I Cappello
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1989;4(4):373-7.
1989: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; F Torresan; Maria Paola Tampieri; P Iannone; Mario Miglioli; L Barbara
5-Aminosalicylic acid suppositories in the management of ulcerative colitis.
Diseases of the colon and rectum 1989;32(5):398-9.
1988: C Brignola; Massimo Campieri; P Farruggia; A Tragnone; S Pasquali; P Iannone; G A Lanfranchi; L Barbara
The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study.
Journal of clinical gastroenterology 1988;10(6):631-4.
1988: Paolo Gionchetti; A Belluzzi; Massimo Campieri; F Torresan; G M Tabanelli; C Brignola; Mario Miglioli; L Barbara
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema.
Methods and findings in experimental and clinical pharmacology 1988;10(10):667-9.
1988: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; G M Tabanelli; F Forresan; Mario Miglioli; L Barbara
Sulphasalazine and new related compounds.
Tropical gastroenterology : official journal of the Digestive Diseases Foundation 1988;9(4):179-83.
1988: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; G M Tabanelli; Mario Miglioli; L Barbara
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
Journal of clinical gastroenterology 1988;10(4):406-9.
1988: G A Lanfranchi; G Bazzocchi; Massimo Campieri; C Brignola; F Fois; B P Imbimbo
Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.
European journal of clinical pharmacology 1988;33(6):571-5.
1987: Massimo Campieri; Paolo Gionchetti; A Belluzzi; C Brignola; Mario Migaldi; G M Tabanelli; G Bazzocchi; Mario Miglioli; L Barbara
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis.
Digestive diseases and sciences 1987;32(12 Suppl):67S-70S.
1987: C Brignola; P Farruggia; Massimo Campieri; G Bazzocchi; A Tragnone; S Pasquali; P Iannone; G Sacco; G A Lanfranchi
Clinical course of Crohn's disease in Italy.
Diseases of the colon and rectum 1987;30(11):875-8.
1986: C Brignola; Massimo Campieri; G Bazzocchi; P Farruggia; A Tragnone; G A Lanfranchi
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.
Gastroenterology 1986;91(6):1490-4.
1986: C Brignola; G A Lanfranchi; Massimo Campieri; G Bazzocchi; M Devoto; P Boni; P Farruggia; S Veggetti; A Tragnone
Importance of laboratory parameters in the evaluation of Crohn's disease activity.
Journal of clinical gastroenterology 1986;8(3 Pt 1):245-8.
1986: Massimo Campieri; G A Lanfranchi; C Brignola; G Bazzocchi; Paolo Gionchetti; M R Minguzzi; I P Cappello; C Corbelli; S Boschi
Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis.
Diseases of the colon and rectum 1986;29(2):108-10.
1985: Piero Del Soldato; Massimo Campieri; C Brignola; G Bazzocchi; Paolo Gionchetti; G A Lanfranchi; M Tamba
A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
Gastroenterology 1985;89(5):1215-6.
1985: Massimo Campieri; G A Lanfranchi; C Brignola; G Bazzochi; Paolo Gionchetti; M R Minguzzi; F Adami
5-aminosalicylic acid for the treatment of inflammatory bowel diseases.
Gastroenterology 1985;89(3):701-3.
1985: Massimo Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; Paolo Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
Gut 1985;26(4):400-5.
1985: G A Lanfranchi; G Bazzocchi; F Fois; C Brignola; Massimo Campieri; B Menni
Effect of domperidone and dopamine on colonic motor activity in patients with the irritable bowel syndrome.
European journal of clinical pharmacology 1985;29(3):307-10.
1984: G A Lanfranchi; G Bazzocchi; C Brignola; Massimo Campieri; G Labò
Different patterns of intestinal transit time and anorectal motility in painful and painless chronic constipation.
Gut 1984;25(12):1352-7.
1984: G A Lanfranchi; G Bazzocchi; S Federici; C Brignola; Massimo Campieri; F Rossi; R Domini; G Labò
Anorectal manometry in the diagnosis of Hirschsprung's disease--comparison with clinical and radiological criteria.
The American journal of gastroenterology 1984;79(4):270-5.
1984: G Bazzocchi; Massimo Campieri; C Brignola; F Fois; A Penna; B Menni
[Effects of Tettuccio water from the Montecatini spa on chronic constipation: clinical evaluation and study of intestinal motor activity].
La Clinica terapeutica 1984;108(6):503-12.
1984: Massimo Campieri; G A Lanfranchi; C Brignola; G Bazzocchi; M R Minguzzi; M T Calari
5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.
Lancet 1984;1(8373):403.
1984: Massimo Campieri; G A Lanfranchi; F Bertoni; C Brignola; G Bazzocchi; M R Minguzzi; G Labò
A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.
Digestion 1984;29(4):204-8.
1983: C Brignola; G A Lanfranchi; R Pasquali; Massimo Campieri; G Bazzocchi; S Veggetti
Calorie supplementation and Crohn's disease.
Lancet 1983;2(8340):47.
1983: G A Lanfranchi; G Bazzocchi; Leonardo Marzio; Massimo Campieri; C Brignola
Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon.
European journal of clinical pharmacology 1983;24(6):769-72.
1982: C Cortini; Massimo Campieri; C Brignola; G Bazzocchi; P Squillantini
[Gastric tolerance of diphenpyramide after long-term treatment. Evaluation of the electric potential difference in the stomach].
La Clinica terapeutica 1982;103(5):521-5.
1982: G A Lanfranchi; C Brignola; Massimo Campieri; G Bazzocchi; M S Rossi
Serum zinc concentrations in Crohn's disease.
Digestive diseases and sciences 1982;27(12):1141-2.
1981: Massimo Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.
Lancet 1981;2(8241):270-1.
1980: G A Lanfranchi; Leonardo Marzio; M Campieri; C Brignola; L Trento
Antispasmodic activity of rociverine. Manometric findings and controlled clinical trial.
Panminerva medica 1980;22(1):7-12.
1980: Massimo Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; A Benatti; S Boccia; G Labo'
Prostaglandins, indomethacin, and ulcerative colitis.
Gastroenterology 1980;78(1):193.
1980: G A Lanfranchi; C Brignola; M Michelini; Massimo Campieri; G Bazzocchi; A Benatti; C Cortini; G Labó; A Parmeggiani
Clinical course of ulcerative colitis in Italy.
Digestion 1980;20(2):106-10.